Results for this period
Third quarter2022年10月1日~2023年6月30日ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
戦略的な案件受注による派遣粗利率の改善、事業運営の効率化、新型コロナウイルス感染症ワクチン接種の看護師派遣、既存支店での堅調な需要の取り込み。
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2022年10月1日~2023年6月30日 |
| Net Sales | ¥13,667 million (YoY +14.0%) |
| Operating profit | ¥428 million (YoY +8.3%) |
| Ordinary income | ¥429 million (YoY +7.4%) |
| Profit attributable to owners of the parent | ¥254 million (YoY +18.2%) |
| Net income per share | 29.98円 |
| Equity ratio | End of the current fiscal period 34.9% / End of previous period 30.5% |
| Total assets | ¥5,028 million |
| Net assets | ¥1,904 million |
| Full-year earnings forecast | Net Sales ¥18,000 million (YoY +10.2%) / Operating profit ¥460 million (YoY +29.1%) / Ordinary income ¥460 million (YoY +25.7%) / Net income ¥270 million (YoY +38.0%) |
| Revision to Earnings Forecast | 本文は2023年8月10日公表資料を参照と記載しているが、修正前後の数値は記載なし |
| Annual Dividend Forecast | ¥0 → ¥0(0.0%) |
| Segment revenue | Senior Work Business ¥3,837 million (YoY +22.5%), Senior Care Business ¥9,830 million (YoY +11.0%) |
| Breakdown of extraordinary income (loss) | Gain on reversal of subscription rights to shares ¥21,610 thousand, Loss on Disposal of Fixed Assets ¥5,256 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 8,624,320 Shares |
| Treasury Shares at Period-End | 118,600 Shares |
| Factors Behind Changes in Business Performance | 戦略的な案件受注による派遣粗利率の改善、事業運営の効率化、新型コロナウイルス感染症ワクチン接種の看護師派遣、既存支店での堅調な需要の取り込み。 |
Items this document does not state (13)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.会社は、ワクチン需要後を見据えた戦略的な案件受注による派遣粗利率の改善と、事業運営の効率化に取り組んだと説明している。また、シニアケア事業では新型コロナウイルス感染症ワクチン接種の看護師派遣と堅調な需要の取り込みが貢献したとしている。